Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness

SIMPLE SUMMARY: The main problem encountered in the management of prostate cancer (PCa) is the inability to distinguish slow-growing indolent tumors from aggressive tumors. It is therefore important to explore non-invasive assays for the early detection of this aggressive subtype, when it can still...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Plazas, Xavier, Altuna-Coy, Antonio, Alves-Santiago, Marta, Vila-Barja, José, García-Fontgivell, Joan Francesc, Martínez-González, Salomé, Segarra-Tomás, José, Chacón, Matilde R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826893/
https://www.ncbi.nlm.nih.gov/pubmed/33440913
http://dx.doi.org/10.3390/cancers13020250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826893/
https://www.ncbi.nlm.nih.gov/pubmed/33440913
http://dx.doi.org/10.3390/cancers13020250

Ejemplares similares